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Cells by TSLP
Thymic stromal lymphopoietin conditions dendritic
cells to support homeostatic proliferation of central
memory T cells. In this issue of Immunity, Wang et al.
(2006) show that these dendritic cells are critical in
maintaining Thelper 2 centralmemory cells and impart
themwith expression of unique proallergic molecules.
Immune responses are initiated upon presentation of
pathogen-derived antigens by activated dendritic cells
(DCs) to lymph node resident naı¨ve T cells. Depending
on the nature of the pathogen, DCs promote the devel-
opment of effector T helper (TH) cells that migrate to
infected tissues where they produce specialized sets
of cytokines upon restimulation by local DCs Protective
TH cells developing in response to intracellular patho-
gens express interferon-g (IFN-g) and are termed TH1
cells, whereas TH2 cells develop in response to para-
sites, in particular helminths, and express the protective
cytokines interleukin-4 (IL-4), IL-5, and IL-13. A well-
established concept is that DCs orchestrate protective
primary T cell responses by sensing the class of patho-
gens they encounter and transferring this information to
naı¨ve T cells via the expression of T cell-polarizing mol-
ecules. In line with this concept, DCs activated upon
recognition of helminthic compounds constitutively
express a specific set of molecules, including OX40L
(de Jong et al., 2002) and Notch-ligand Jagged (Amsen
et al., 2004), that promote the development of naı¨ve
T cells into TH2 cells.
In addition to direct activation via pathogens, DCs can
also be activated and conditioned by factors produced
by tissue cells. An example of such a tissue factor is
thymic stromal lymphopoietin (TSLP), which is produced
under homeostatic conditions in the thymus, as well as in
epithelium of mucosal tissues (Watanabe et al., 2004;
Rimoldi et al., 2005) and found at high amounts in skin
affected by atopic dermatitis (Soumelis et al., 2002),
and in bronchial epithelium and submucosa in allergic
asthma (Ying et al., 2005). Liu and colleagues (Soumelis
et al., 2002; Ito et al., 2005) were the first to discover that
TSLP is a strong activator of DCs that drive naı¨ve TH cells
to develop into an ‘inflammatory type’ of effector TH2 cell
expressing classical TH2 cytokines and large amounts of
pro-inflammatory tumor necrosis factor-a (TNF-a) but no
anti-inflammatory IL-10. As for helminthic compounds,
TSLP drives the development of TH2 cells via its intrinsic
ability to imprint DCs for the expression of OX40L (Ito
et al., 2005). As allergy is causally related to the activity
of allergen-specific TH2 cells, this finding has prompted
the hypothesis that TSLP is critical in the development
and maintenance of atopic allergic disease, a concept
that was recently validated in TSLP-deficient and
TSLP-transgenic mouse models.
TSLP may not only be associated with immunity.
When testing epithelial cell line supernatants, Rescignoand colleagues (Rimoldi et al., 2005) found that TSLP
is a critical component in conditioning DCs to induce
‘‘noninflammatory’’ effector TH2 cells producing the
classical TH2 cytokines in combination with anti-inflam-
matory IL-10. They propose that, as such, homeostatic
expression of intestinal epithelial TSLP contributes
to local tolerance, counteracting the TH1-inducing prop-
erties of gut commensals. Their data further reveal
that Crohn’s disease is associated with a loss of TSLP-
mediated homeostatic control.
Apart from DC-driven activation of naı¨ve TH cells re-
sulting in immunity mediated by ‘‘inflammatory’’ effector
TH2 cells or in tolerance mediated by ‘‘noninflammatory’’
effector TH2 cells, TSLP also affects established memory
T cells. TH2 cells producing high amounts of cytokines in
peripheral tissues represent short-lived effector memory
TH (TEM) cells. However, long-term protection is sup-
ported by a separate subset of long-lived central mem-
ory T (TCM) cells that home to lymphoid tissue, and
may become effector T cells upon secondary stimulation
(Lanzavecchia and Sallusto, 2005). TCM cells maintain
their numbers by continuously dividing, which in humans
is driven by the cytokines IL-7 and IL-15, and this re-
sponse can be enhanced by DCs. An important step in
understanding how DCs contribute to homeostatic pro-
liferation of memory T cells is offered by the previous
finding by Liu and colleagues (Watanabe et al., 2004) that
TSLP-primed DCs (TSLP-DCs), and not DCs that have
been primed differently, are capable of stimulating
long-term proliferation of both naı¨ve T and TCM cells in
the absence of antigen. Although the expression of
OX40L is critical in the induction of this homeostatic pro-
liferation, OX40L in the absence of antigen does not ad-
ditionally skew naı¨ve T cells toward a TH2 phenotype.
In this issue of Immunity, Wang et al. (2006) extend
these findings by reporting that TSLP-DCs, in particular,
support homeostatic proliferation of central memory
TH2 cells (TH2 TCM), the CRTH2
+ cells in blood, thereby
exceeding the potential of the classical combination of
the homeostatic cytokines IL-7 and IL-15 to enhance
their proliferation. Strikingly, even after multiple rounds
of TSLP-DC-driven proliferation, CRTH2+ TH2 TCM cells
maintain their central memory phenotype and their
strictly TH2-biased cytokine profile. In contrast, CRTH2
+
TCM cells that proliferate less vigorously in response to
homeostatic cytokines or to other DCs tend to lose their
central memory phenotype, and many acquire expres-
sion of the TH1 cytokine IFN-g. In addition, TSLP-DC-
induced TH2 TCM cells were found to transcribe genes
coding for cystatin A, Charcot-Leydon crystal protein,
and prostaglandin D2 synthetase, which are molecules
known to be uniquely expressed by eosinophils and
basophils, and further contribute to allergic inflamma-
tion. Thus, TSLP-DCs not only maintain the central
memory phenotype, but also further strengthen the
allergy-inducing TH2 properties of the CDTH2
+ TH2 TCM.
As TH cell expression of these additional proallergic
genes has not been shown before, this interesting
finding needs to be confirmed at the level of protein
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674Figure 1. TSLP in Homeostatic Maintenance
and Further Tuning of Central Memory TH2
Cells
Homeostatic amounts of intestinal epithelial
cell-derived TSLP (left panel) prime DCs that
promote naı¨ve TH cells (THN) to develop into
‘‘noninflammatory’’-type of effector memory
TH2 (TH2 TEM, light blue) cells. These cells pre-
vent inflammation to commensal bacteria
that potentially induce TH1 responses. In al-
lergic conditions, high amounts of airway or
skin epithelium-derived TSLP primes DCs
that induce ‘‘inflammatory’’ type effector
memory TH2 (TH2 TEM, dark blue) cells. These
TH2 TEM cells initiate allergic inflammation to
harmless environmental proteins (red dots).
During any immune response, a pool of cen-
tral memory TH2 (TH2 TCM) cells additionally
develops, which keeps its size by homeo-
static proliferation in response to TSLP-
primed DCs in the absence of allergen, and
that may become TH2 TEM upon antigen chal-
lenge. The study by Liu and colleagues (Wang
et al., 2006) in this issue of Immunity shows
that TSLP-primed DCs are superior in
promoting homeostatic proliferation of TH2
TCM cells in the absence of antigen, and fur-
ther empower these cells (TH2 TCM, purple)
by inducing the expression of allergy-associ-
ated genes that have been detected only in
eosinophils and basophils, thus far.expression. In addition, establishing a role for these cells
in vivo is of paramount importance. According to the
present study, these genes are not expressed in circulat-
ing TH2 cells of healthy individuals. However, it is reason-
able to assume that they may appear during, or after,
acute disease associated with enhanced TLSP expres-
sion, such as allergy. Unfortunately, whereas the authors
provide details on the physical association between
CRTH2+ cells and DCs in atopic dermatitis skin, they
do not report to what extent these skin-homing T cells
are TH2 cells expressing the additional proallergic genes
documented in the vitro experiments, nor did they report
on the phenotype of the CRTH2+ TH2 TCM counterparts in
the circulation of these patients. It will be interesting to
fully establish the physiological significance of the em-
powered TH2 TCM phenotype generated in vitro.
Obviously, whereas atopic allergy represents TH2-
mediated pathology, TH2-associated immunity has
evolved to provide protection against helminth infection.
Helminths are complex organisms which effectively
evade immunity in many ways, resulting in chronic infec-
tion. It is tempting to speculate that the proposed TSLP-
DC-induced enhancement of the TH2 phenotype has
evolved to arm TH2 TCM cells with additional molecules
effective in the defense against parasites in the chronic
phase of disease. Analysis of the presence of these em-
powered cells in acute and chronic helminthic infection
may further elucidate their physiological role in order to
exclude the possibility that these cells merely represent
pathological misfits associated with allergic disease.
Altogether, the data discussed above lead to the
attractive concept that extra-thymic TSLP controls TH
cells at different stages of differentiation (Figure 1).
According to the study of Rescigno and colleagues
(Rimoldi et al., 2005), homeostatic amounts of TSLP
produced by mucosal epithelial cells, in the context ofother mediators, condition DCs to induce the develop-
ment of ‘‘noninflammatory’’ TH2 TEM cells specific to
commensals, which counteracts the potential of these
microorganisms to induce TH1-responses evoked by
these organisms. The earlier studies of Liu et al. (Wata-
nabe et al., 2004) further suggest that, at the same time,
a pool of TH2 TCM TH cells is generated, which is main-
tained by TSLP-conditioned DCs carrying irrelevant
antigens. Furthermore, in conditions of high amounts
of TSLP, TSLP-conditioned DCs induce ‘‘inflammatory’’
TH2 TEM cells (Ito et al., 2005) that are pathological in
allergic reactions to harmless environmental proteins,
while they may be effective in protection against hel-
minths. The present study represents an important step
forward by expanding the concept of TSLP control of
immune cells, indicating for the first time that such
TSLP-conditioned DCs are critical in the maintenance
of TH2 TCM homeostasis. Importantly, the study further-
more shows that during TSLP-driven homeostatic pro-
liferation, TH2 TCM cells acquire the expression of addi-
tional proallergic molecules, which would render them
more powerful in TH2-type inflammation.
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